[1] 江基尧,朱波,罗其中.颅脑创伤临床救治指南[M]. 3版. 上海:上海第二军医大学出版社,2007:1-241.[2] Schouten JW, Fulp CT, Royo NC, et al. A review and rationale for the use of cellular transplantation as a therapeutic strategy for traumatic brain injury. J Neurotrauma. 2004;21(11): 1501-1538.[3] 陈镭,苗宗宁,张东强,等.人脐血源性间充质干细胞的体外培养及生物学鉴定[J].江苏医药,2005,31(7):481-483.[4] Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147.[5] Mareschi K, Biasin E, Piacibello W, et al. Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica. 2001;86(10):1099-1100.[6] Li JP, Wang DW, Song QH. Transplantation of erythropoietin gene-transfected umbilical cord mesenchymal stem cells as a treatment for limb ischemia in rats. Genet Mol Res. 2015; 14(4):19005-19015.[7] 陈镭,惠国桢,张赛,等.人脐血间充质干细胞移植促进大鼠颅脑创伤后神经功能的恢复[J].中华创伤杂志,2009,25(6):498-502.[8] Abboud A, Mi Q, Puccio A, et al. Inflammation Following Traumatic Brain Injury in Humans: Insights from Data-Driven and Mechanistic Models into Survival and Death. Front Pharmacol. 2016;7:342. [9] Aerts JM, Haddad WM, An G, et al. From data patterns to mechanistic models in acute critical illness. J Crit Care. 2014;29(4):604-610.[10] Centers for Disease Control and Prevention (CDC). CDC grand rounds: reducing severe traumatic brain injury in the United States. MMWR Morb Mortal Wkly Rep. 2013;62(27): 549-552.[11] Newell E, Shellington DK, Simon DW, et al. Cerebrospinal Fluid Markers of Macrophage and Lymphocyte Activation After Traumatic Brain Injury in Children. Pediatr Crit Care Med. 2015;16(6):549-557.[12] Hinson HE, Rowell S, Schreiber M. Clinical evidence of inflammation driving secondary brain injury: a systematic review. J Trauma Acute Care Surg. 2015;78(1):184-191.[13] Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428-435.[14] Maas AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7(8): 728-741.[15] McIntosh TK. Neurochemical sequelae of traumatic brain injury: therapeutic implications. Cerebrovasc Brain Metab Rev. 1994;6(2):109-162.[16] Caplan AI.Mesenchymal stem cells. J Orthop Res. 1991;9(5): 641-650.[17] Lozano D, Gonzales-Portillo GS, Acosta S, et al. Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatr Dis Treat. 2015;11:97-106.[18] 迟作华,张洹,何冬梅,等.脐血间充质干细胞培养条件的优化[J].中国实用内科杂志:临床版,2006,26(5):372-375.[19] Cui B, Li E, Yang B, et al. Human umbilical cord blood-derived mesenchymal stem cell transplantation for the treatment of spinal cord injury. Exp Ther Med. 2014;7(5):1233-1236.[20] Tepper OM, Galiano RD, Kalka C, et al. Endothelial progenitor cells: the promise of vascular stem cells for plastic surgery. Plast Reconstr Surg. 2003;111(2):846-854.[21] Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147.[22] Freitas AL, Oliveira e Silva Md, Matsumoto PM, et al. Experimental model of obtaining tissue adipose, mesenchymal stem cells isolation and distribution in surgery flaps in rats. Acta Cir Bras. 2014;29 Suppl 2:29-33.[23] 谷涌泉,韩忠朝,付小兵.干细胞临床研究与应用[M].北京:人民卫生出版社,2012.[24] 韩忠朝.间充质干细胞基础与临床[M].北京:科学出版社,2012: 1-90.[25] 陶凯,全亮亮.再生医学丛书-组织工程学[M].沈阳:辽宁科学技术出版社,2016:19-31.[26] 刘新峰.脑血管病介入治疗学[M]. 2版.北京:人民卫生出版社, 2012:1-50. |